BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8533168)

  • 1. Genetic susceptibility to Alzheimer disease.
    Pericak-Vance MA; Haines JL
    Trends Genet; 1995 Dec; 11(12):504-8. PubMed ID: 8533168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other beta-amyloid-forming diseases.
    Pickering-Brown SM; Mann DM; Bourke JP; Roberts DA; Balderson D; Burns A; Byrne J; Owen F
    Lancet; 1994 May; 343(8906):1155. PubMed ID: 7818636
    [No Abstract]   [Full Text] [Related]  

  • 3. Apolipoprotein E and Alzheimer's disease.
    Stephens D
    J R Soc Health; 1996 Feb; 116(1):41-3. PubMed ID: 8683540
    [No Abstract]   [Full Text] [Related]  

  • 4. A quartet of Down's syndrome, Alzheimer's disease, cerebral amyloid angiopathy, and cerebral haemorrhage: interacting genetic risk factors.
    McCarron MO; Nicoll JA; Graham DI
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):405-6. PubMed ID: 9728967
    [No Abstract]   [Full Text] [Related]  

  • 5. The genetics of late-onset Alzheimer's disease.
    Myers AJ; Goate AM
    Curr Opin Neurol; 2001 Aug; 14(4):433-40. PubMed ID: 11470958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease: identification of genes and genetic risk factors.
    Van Broeckhoven C
    Prog Brain Res; 1998; 117():315-25. PubMed ID: 9932417
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidants and dementia.
    Lethem R; Orrell M
    Lancet; 1997 Apr; 349(9060):1189-90. PubMed ID: 9130937
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype.
    Strittmatter WJ; Weisgraber KH; Goedert M; Saunders AM; Huang D; Corder EH; Dong LM; Jakes R; Alberts MJ; Gilbert JR
    Exp Neurol; 1994 Feb; 125(2):163-71; discussion 172-4. PubMed ID: 8313935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetics of Alzheimer disease: current status and future prospects.
    Blacker D; Tanzi RE
    Arch Neurol; 1998 Mar; 55(3):294-6. PubMed ID: 9520001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the genetics of Alzheimer's disease.
    Levy-Lahad E; Tsuang D; Bird TD
    J Geriatr Psychiatry Neurol; 1998; 11(2):42-54. PubMed ID: 9877525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New frontiers in Alzheimer's disease genetics.
    Tanzi RE; Bertram L
    Neuron; 2001 Oct; 32(2):181-4. PubMed ID: 11683989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genes in Alzheimer's disease].
    Hoenicka J
    Rev Neurol; 2006 Mar 1-15; 42(5):302-5. PubMed ID: 16538594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome).
    Hyman BT; West HL; Rebeck GW; Buldyrev SV; Mantegna RN; Ukleja M; Havlin S; Stanley HE
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3586-90. PubMed ID: 7724603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E, A beta-amyloid, and the molecular pathology of Alzheimer's disease. Therapeutic implications.
    Kaplitt M; Gouras GK; Makimura H; Jovanovic J; Sweeney D; Greengard P; Relkin NR; Gandy S
    Ann N Y Acad Sci; 1996 Dec; 802():42-9. PubMed ID: 8993483
    [No Abstract]   [Full Text] [Related]  

  • 16. Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12.
    Pericak-Vance MA; Bass MP; Yamaoka LH; Gaskell PC; Scott WK; Terwedow HA; Menold MM; Conneally PM; Small GW; Vance JM; Saunders AM; Roses AD; Haines JL
    JAMA; 1997 Oct; 278(15):1237-41. PubMed ID: 9333264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linkage of late-onset Alzheimer's disease with apolipoprotein E type 4 on chromosome 19.
    Borgaonkar DS; Schmidt LC; Martin SE; Kanzer MD; Edelsohn L; Growdon J; Farrer LA
    Lancet; 1993 Sep; 342(8871):625. PubMed ID: 8102761
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current genetic linkages of Alzheimer's disease].
    Haltia M
    Duodecim; 1995; 111(5):389-92. PubMed ID: 8674440
    [No Abstract]   [Full Text] [Related]  

  • 19. Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases.
    Saunders AM; Schmader K; Breitner JC; Benson MD; Brown WT; Goldfarb L; Goldgaber D; Manwaring MG; Szymanski MH; McCown N
    Lancet; 1993 Sep; 342(8873):710-1. PubMed ID: 8103823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current status of Alzheimer's disease genetics: what do we tell the patients?
    Bertram L; Tanzi RE
    Pharmacol Res; 2004 Oct; 50(4):385-96. PubMed ID: 15304236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.